International Ophthalmology

, Volume 19, Issue 5, pp 271–280

The global burden of trachomatous visual impairment: II. assessing burden

  • Timothy G. Evans
  • M. Kent Ranson
Articles

Abstract

This paper builds on results of a previous paper on the prevalence of trachomatous visual impairment as the foundation for assessing the global burden of trachomatous blindness and low vision: approximately 2.9 million cases of trachomatous blindness and 3.8 million low visioned corresponding to a global prevalence of trachomatous visual impairment equal to 1.3/1,000 in 1990 was estimated. For each visually impaired person, the years of life lost due to premature mortality and the years lived in a handicapped state are added to yield a single measure of disease burden called handicap adjusted life years (HALYs). Age, gender and visual acuity group specific HALYs are multiplied by the prevalence of trachomatous visual impairment to yield an estimate of the global burden of trachoma visual impairment equal to 80 million HALYs. Analysis of the distribution of the global burden by age, gender, visual acuity and region provide direction for trachoma research and programme priorities. Sensitivity analysis reveals that the burden estimates of trachomatous visual impairment may vary from as low as 15 million to as high as 500 million HALYs. Given this degree of variability, burden comparisons with other blinding and non-blinding conditions for the purposes of identifying health sector priorities may be misleading.

Key words

blindness burden of disease low vision prevalence trachoma visual impairment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sullivan DF. Conceptual problems in developing an index of health. US Public Health Service Publication Series No. 1000. Vital and Health Statistics Series 2. No. 17. Bethesda MD, National Center for Health Statistics, 1966.Google Scholar
  2. 2.
    Sullivan DF A single index of mortality and morbidity. Health Reports 1976; 86: 347–54.Google Scholar
  3. 3.
    World Bank. World Development Report 1993: Investing in Health. Oxford University Press, New York, 1993.Google Scholar
  4. 4.
    Murray C. Quantifying the burden of disease: the technical basis for Disability Adjusted Life Years. Bull World Health Organ 1994; 72 (3): 429–45.Google Scholar
  5. 5.
    Evans TG, Ranson MK. 1996 The global burden of trachomatous visual impairment: 1. Assessing prevalence. Int Ophthalmol 19: 261–270 (in this issue).Google Scholar
  6. 6.
    Thylefors B, Evans TG, Ranson MK. Blindness as a risk factor: assessing the health impact of visual impairment. In: Murray CJL, Lopez A (eds) The Global Burden of Disease (forthcoming).Google Scholar
  7. 7.
    Evans TG, Ranson MK. The burden of trachomatous visual impairment. Harvard Center for Population and Development Studies Working Paper Series, Cambridge (in preparation).Google Scholar
  8. 8.
    World Health Organization. The prevention of blindness. Technical Report Series, No. 518. WHO, Geneva, 1973.Google Scholar
  9. 9.
    Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford Medical Publications, New York, 1987.Google Scholar
  10. 10.
    Kirkwood B, Smith P, Marshall T, Prost A. Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg 1983; 77 (6): 862–8.Google Scholar
  11. 11.
    Chandran PKG, Lane T, Flynn CT. Patient and technique survival for blind and sighted diabetics on continuous ambulatory peritoneal dialysis: a ten-year analysis. Int J Artif Organs 1991; 14 (5): 262–8.Google Scholar
  12. 12.
    Laforge RG, Spector WD, Sternberg J. The relationship of vision and hearing impairment to one-year mortality and functional decline. Vision and Hearing Impairment February 1992: 126-48.Google Scholar
  13. 13.
    Taylor HR, Katala S, Muñoz B, Turner V. Increase in mortality associated with blindness in rural Africa. Bull WHO 1991; 69 (3): 335–8.Google Scholar
  14. 14.
    Rogot E, Goldberg ID, Goldstein H. Survivorship and causes of death among the blind. J Chron Dis 1966; 19: 179–97.Google Scholar
  15. 15.
    Coale AJ, Goa G. Revised regional model life tables at very low levels of mortality. Population Index 1989; 55 (4): 613–43.Google Scholar
  16. 16.
    Evans TG. The socio-economic consequences of blinding onchocerciasis in West Africa. Bull WHO (forthcoming).Google Scholar
  17. 17.
    Evans TG. The impact of permanent disability on rural households: river blindness in Guinea. IDS Bulletin 1989; 20 (2): 41–8.Google Scholar
  18. 18.
    Drummond MF, Stoddart G, Torrance GW. Principles of Economic Appraisal in Health Care. Oxford University Press, Oxford, 1980.Google Scholar
  19. 19.
    Kirkwood BR. Essentials of Medical Statistics. Blackwell Scientific Publications, Oxford, 1988.Google Scholar
  20. 20.
    Freeman J, Hutchison CB. Prevalence, incidence and duration. Am J Epidemiol 1980; 112: 707.Google Scholar
  21. 21.
    Courtright PJ, Sheppard B, Mihkail B, Manka R, Dawson CR. Adult-associated risk factors for cicatricial trachoma in Egyptian women. Abstract ARVO 1988 May.Google Scholar
  22. 22.
    Kupka K, Nizetic B, Reinhards J. Sampling studies on the epidemiology and control of trachoma in southern Morocco. Bull World Health Organ 1968; 39: 547–66.Google Scholar
  23. 23.
    Turner VM, West SK, Muñoz B, Katala SJ, Taylor HR, Halsey N, Mmbaga BBO. Risk factors for trichiasis in women in Kongwa, Tanzania: a case-control study. Int J Epidemiol 1993; 22(2): 341–7.Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Timothy G. Evans
    • 1
  • M. Kent Ranson
    • 1
  1. 1.Center for Population and Development Studies, School of Public Health, Harvard UniversityUSA
  2. 2.Harvard Center for Population and Development Studies, Roger and Ellen Revelle BuildingCambridgeUSA

Personalised recommendations